US Patent 7300938 Polymorphs of imatinib mesylate
Patent 7300938 was granted and assigned to Hetero Drugs on November, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+173 characters)
Article
Patent abstract
The present invention relates to novel polymorphs of imatinib mesylate, to processes for their preparation and to pharmaceutical compositions containing them.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07300938 Polymorphs of imatinib mesylate US Patent 7300938 Polymorphs of imatinib mesylate
Infobox
Patent Number
0730093800
Patent Number
730093800
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
073009380
Date of Patent
November 27, 2007
0Patent Application Number
105182130
Date Filed
June 2, 2003
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
073009380
Date of Patent
November 27, 2007
0Patent Application Number
105182130
Date Filed
June 2, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07300938 Polymorphs of imatinib mesylate
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07300938
Date of patent
November 27, 2007
Patent application number
10518213
Date Filed
June 2, 2003
Patent primary examiner
Find more entities like US Patent 7300938 Polymorphs of imatinib mesylate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
